N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects

n-of-1 trial in 60 patients who previously discontinued statins due to side effects that occurred within 2 weeks after treatment initiation found 90% of symptom burden caused by statin challenge was elicited by placebo and half of the trial patients successfully restarted statins

New England Journal of Medicine